Thais Baert
Essen, NW 45136, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 16, 2025
A multidisciplinary management approach to cervical cancer during pregnancy.
Journal: Lancet (London, England)
Published: October 23, 2025
First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: September 30, 2025
Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study.
Journal: Brachytherapy
Published: July 04, 2025
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE).
Journal: Brain sciences
Published: July 03, 2025
Value of whole-body diffusion-weighted MRI for the prediction of surgical and clinical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Journal: British journal of cancer
Published: July 01, 2025
Single-cell profiling in ovarian germ cell and sex cord-stromal tumours.
Journal: British journal of cancer
Published: November 13, 2024
Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer.
Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: October 23, 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 07, 2024
Alterations in the MAPK pathway: promising biomarkers for MEK1/2 inhibition.
Journal: Gynecology and pelvic medicine
Published: December 05, 2023
Last Updated: 09/26/2026